8-K: Tivic Health Appoints Odyssey as New Transfer Agent

Sentiment:

Administrative Update


Tivic Health Systems, Inc. has appointed Odyssey Transfer and Trust Company as its new transfer agent and registrar, effective August 30, 2025, replacing Equiniti Trust Company, LLC.

Summary

  • Tivic Health Systems, Inc. has appointed Odyssey Transfer and Trust Company (Odyssey) to serve as its new transfer agent and registrar.
  • The appointment is effective as of August 30, 2025.
  • Odyssey will replace Equiniti Trust Company, LLC (Equiniti), the company's prior transfer agent and registrar.
  • All registered shares of common stock and related records will be transferred from Equiniti to Odyssey on or before the effective date.
  • Odyssey will also replace Equiniti as the successor warrant agent for Series B Warrants, which were originally issued on May 13, 2024.

Sentiment

Score: 5

Explanation: The filing reports a routine administrative change in transfer agent and registrar, which is neutral in terms of company performance or strategic direction.

Positives

  • No explicit positives are detailed in this administrative filing, as it reports a routine operational change.

Negatives

  • No explicit negatives are detailed in this administrative filing, as it reports a routine operational change.

Risks

  • No specific risks are mentioned in the filing related to this administrative change.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's financial performance or strategic direction.

Management Comments

  • Jennifer Ernst, Chief Executive Officer, duly caused the report to be signed on behalf of Tivic Health Systems, Inc.

Industry Context

The appointment of a new transfer agent is a routine administrative change for publicly traded companies, ensuring efficient management of shareholder records and warrant administration. This type of change does not typically reflect broader industry trends but rather internal operational adjustments.

Comparison to Industry Standards

  • This is a standard administrative procedure for publicly traded companies. There are no specific comparable companies, projects, or results mentioned in the filing to assess against industry benchmarks.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Service Provider ChangeThe company changed its transfer agent and registrar from Equiniti Trust Company, LLC to Odyssey Transfer and Trust Company. This impacts the administrative aspect of corporate governance related to shareholder record-keeping and warrant management.August 30, 2025This is an administrative change that ensures the continued efficient management of shareholder records and warrant administration. It does not represent a change in the company's governance structure, bylaws, or board committees.

Stakeholder Impact

  • Shareholders: Will interact with a new entity (Odyssey Transfer and Trust Company) for stock-related inquiries, transfers, and warrant exercises.
  • Employees, Customers, Suppliers, Creditors: No direct impact from this administrative change.

Next Steps

  • Transfer of all registered shares of common stock and related records from Equiniti Trust Company, LLC to Odyssey Transfer and Trust Company on or before August 30, 2025.
  • Odyssey Transfer and Trust Company will assume duties as successor warrant agent for Series B Warrants as of August 30, 2025.

Key Dates

DateDescription
May 13, 2024Original Warrant Agency Agreement entered into by the Company and Equiniti for Series B Warrants.
August 27, 2025Date of earliest event reported and filing date of the Form 8-K.
August 30, 2025Effective date for Odyssey Transfer and Trust Company's appointment as the new transfer agent, registrar, and successor warrant agent.

Keywords

Tivic Health Systems, TIVC, transfer agent, registrar, warrant agent, corporate governance, SEC filing, 8-K

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.